Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gastroenterology · Blue Rubber Bleb Nevus Syndrome

Treatment Strategies: Medication, Procedures, and Surgery

At a Glance

Blue Rubber Bleb Nevus Syndrome (BRBNS) treatment focuses on minimizing gastrointestinal bleeding and managing anemia. The targeted medication Sirolimus is highly effective for shrinking lesions, while endoscopic procedures and surgery are used for severe or actively bleeding spots.

Because Blue Rubber Bleb Nevus Syndrome (BRBNS) is a complex, multi-system condition, there is no “one-size-fits-all” treatment. Instead, your care team will likely use a combination of therapies to manage symptoms and prevent complications [1][2]. The goal is to minimize bleeding, maintain healthy iron levels, and improve your quality of life.

Targeted Medical Therapy: Sirolimus

In recent years, Sirolimus (also known as rapamycin) has become a cornerstone of BRBNS treatment [3][4].

  • How it works: Sirolimus is an mTOR inhibitor. It acts as a “brake” on the overactive growth signals (the PI3K/AKT/mTOR pathway) that cause your malformed veins to grow and leak [5][6].
  • Format: It is taken daily as an oral pill or liquid solution [4].
  • Effectiveness: For many patients, Sirolimus is highly effective at shrinking both skin and internal lesions [7][8]. It can significantly reduce or even stop gastrointestinal (GI) bleeding, which often eliminates the need for frequent blood transfusions [9][6].

Important Safety Warnings for Sirolimus:

  • Drug/Food Interactions: Sirolimus interacts strongly with certain foods, specifically grapefruit and Seville oranges. Consuming these can dangerously spike the levels of the drug in your blood. Always consult your pharmacist before starting any new medication or supplement [10].
  • Pregnancy and Family Planning: Because Sirolimus alters cell growth and mildly suppresses the immune system, it is crucial to discuss family planning with your doctor before starting this medication if you are of childbearing age [10].

Spot Treatments: Endoscopic Interventions

When lesions in the stomach or intestines are actively bleeding, doctors may use an endoscope (a thin tube with a camera) to treat them directly without surgery [11][12].

  • Sclerotherapy: A doctor injects a special medicine into the malformation that causes it to shrink and scar over [12][13].
  • Band Ligation: A tiny rubber band is placed around the lesion to cut off its blood supply, causing it to eventually wither away [12][14].
  • Argon Plasma Coagulation (APC): A jet of ionized argon gas and electricity is used to “seal” the surface of the bleeding veins [15][14]. Note: Because BRBNS lesions often have very thin walls, treatments like APC carry a risk of bowel perforation (creating a hole in the intestine), which requires careful consideration by an experienced gastroenterologist [14].

Traditional Approaches: Surgery

Surgical Resection involves removing the segment of the intestine that contains the most problematic lesions [16][2].

  • When it’s used: Because BRBNS usually involves many lesions throughout the gut, surgery is typically reserved for severe cases where bleeding cannot be controlled by other means, or if a lesion causes a complication like an intestinal blockage (intussusception) [16][17].

Supportive Care

Regardless of other treatments, most patients will need supportive care to manage the effects of chronic bleeding [1].

  • Iron Infusions: Since the gut often loses iron faster than you can eat it, intravenous (IV) iron is frequently used to boost energy and hemoglobin [3][11].
  • Blood Transfusions: In cases of severe or sudden blood loss, a transfusion may be necessary to stabilize your health [8][9].

Choosing the Right Path

Your doctors will likely follow a logical “decision tree” to determine the best approach:

If you have… The typical first step is…
Mild anemia or few symptoms Supportive care (Iron supplements/monitoring).
Frequent bleeding or many lesions Sirolimus (to manage the whole body at once) [3].
A few specific, actively bleeding spots Endoscopic “spot” treatments (APC or Banding) [12].
Severe bleeding unresponsive to meds Surgical resection of the affected bowel area [16].

It is common to use several of these methods together. For example, you might take Sirolimus to shrink most of your lesions while also having an endoscopic procedure to “zap” a particularly stubborn bleeding spot [3][15].

Common questions in this guide

Should I start with Sirolimus or try endoscopic treatments first for BRBNS?
The choice depends on the extent of your gastrointestinal lesions. Sirolimus is often used to manage multiple lesions throughout the body simultaneously, while endoscopic treatments are typically used to stop a few specific, actively bleeding spots.
What foods should I avoid while taking Sirolimus?
You must strictly avoid grapefruit and Seville oranges while taking Sirolimus. Consuming these fruits can cause the levels of the drug in your blood to spike to dangerous levels.
When is surgery necessary for Blue Rubber Bleb Nevus Syndrome?
Surgical resection is typically reserved for severe cases where bleeding cannot be controlled by medications or endoscopic procedures. It may also be required if a lesion causes a dangerous complication like an intestinal blockage.
How is chronic bleeding and anemia managed in BRBNS?
Chronic blood loss from gastrointestinal lesions often depletes iron levels faster than you can replace them through diet. Doctors frequently use intravenous iron infusions or blood transfusions to safely boost your hemoglobin and stabilize your health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the extent of my GI lesions, should we start with Sirolimus or try endoscopic treatments first?
  2. 2.What is the goal for my hemoglobin levels, and how long should I expect to stay on Sirolimus?
  3. 3.At what point would we consider surgical resection as a necessary option rather than an elective one?
  4. 4.Are there specific medications or foods, like grapefruit, I must strictly avoid while taking an mTOR inhibitor?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Diagnosis and management of children with Blue Rubber Bleb Nevus Syndrome: A multi-center case series.

    Isoldi S, Belsha D, Yeop I, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(11)):1537-1546 doi:10.1016/j.dld.2019.04.020.

    PMID: 31358484
  2. 2

    Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment.

    Salloum R, Fox CE, Alvarez-Allende CR, et al.

    Pediatric blood & cancer 2016; (63(11)):1911-4 doi:10.1002/pbc.26049.

    PMID: 27273326
  3. 3

    Case Report: Combination of sirolimus and endoscopic lauromacrogol sclerotherapy in the management of blue rubber bleb nevus syndrome with gastric tract bleeding.

    Liu L, Wang L, Hu F

    Frontiers in pediatrics 2024; (12()):1488466 doi:10.3389/fped.2024.1488466.

    PMID: 39867693
  4. 4

    Sirolimus in the Management of Blue Rubber Bleb Nevus Syndrome: A Case Report and Review of the Literature.

    AlNooh BM, AlQadri NG, Alghubayn M, AlAjlan SM

    Case reports in dermatology 2021; (13(2)):417-421 doi:10.1159/000511535.

    PMID: 34594200
  5. 5

    Sirolimus as a promising drug therapy for blue rubber bleb nevus syndrome: Two-case report.

    Ma JX, Xia YC, Zou LP, et al.

    SAGE open medical case reports 2022; (10()):2050313X221097755 doi:10.1177/2050313X221097755.

    PMID: 35573101
  6. 6

    Sirolimus alternative to blood transfusion as a life saver in blue rubber bleb nevus syndrome: A case report.

    Wang KL, Ma SF, Pang LY, et al.

    Medicine 2018; (97(8)):e9453 doi:10.1097/MD.0000000000009453.

    PMID: 29465551
  7. 7

    Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias.

    Sun Q, Wu JC, Chen X, et al.

    World journal of gastroenterology 2025; (31(25)):105677 doi:10.3748/wjg.v31.i25.105677.

    PMID: 40656607
  8. 8

    Efficacy and Safety of Sirolimus for Blue Rubber Bleb Nevus Syndrome: A Prospective Study.

    Zhou J, Zhao Z, Sun T, et al.

    The American journal of gastroenterology 2021; (116(5)):1044-1052 doi:10.14309/ajg.0000000000001117.

    PMID: 33416235
  9. 9

    Successful Management of Blue Rubber Bleb Nevus Syndrome (BRBNS) with Sirolimus.

    Ogu UO, Abusin G, Abu-Arja RF, Staber JM

    Case reports in pediatrics 2018; (2018()):7654278 doi:10.1155/2018/7654278.

    PMID: 30402320
  10. 10

    Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series.

    Duong JT, Geddis A, Carlberg K, et al.

    Pediatric blood & cancer 2022; (69(11)):e29970 doi:10.1002/pbc.29970.

    PMID: 36094280
  11. 11

    Endoscopic Band Ligation in Blue Rubber Bleb Nevus Syndrome: A Report of Two Children.

    Samanta A, Poddar U, Sarma MS, et al.

    JPGN reports 2023; (4(4)):e344 doi:10.1097/PG9.0000000000000344.

    PMID: 38034424
  12. 12

    Endoscopic treatment of blue rubber bleb nevus syndrome in a 4-year-old girl with long-term follow-up: A case report.

    Marakhouski K, Sharafanovich E, Kolbik U, et al.

    World journal of gastrointestinal endoscopy 2021; (13(3)):90-96 doi:10.4253/wjge.v13.i3.90.

    PMID: 33763189
  13. 13

    Managing gastrointestinal involvement in cutaneomucosal venous malformation: safety and efficacy of endoscopic sclerotherapy.

    Zhu J, Liu W, Zhang Z, et al.

    Hereditas 2025; (162(1)):113 doi:10.1186/s41065-025-00486-5.

    PMID: 40551278
  14. 14

    An endoscopic multimodal approach in a patient with blue rubber bleb nevus syndrome and acute bleeding.

    Campos-Murguía A, Zamora-Nava LE

    Endoscopy 2021; (53(9)):E338-E339 doi:10.1055/a-1287-8987.

    PMID: 33175995
  15. 15

    Blue rubber bleb nevus syndrome complicated with disseminated intravascular coagulation and intestinal obstruction: A case report.

    Zhai JH, Li SX, Jin G, et al.

    World journal of clinical cases 2022; (10(32)):11929-11935 doi:10.12998/wjcc.v10.i32.11929.

    PMID: 36405278
  16. 16

    Endoscopic and Surgical Management of Blue Rubber Bleb Nevus Syndrome.

    Suarez ZK, Castaneda D, Gonzalez A, et al.

    ACG case reports journal 2022; (9(10)):e00890 doi:10.14309/crj.0000000000000890.

    PMID: 36277742
  17. 17

    Blue rubber bleb nevus syndrome with the complication of intussusception: A case report and literature review.

    Hu Z, Lin X, Zhong J, et al.

    Medicine 2020; (99(28)):e21199 doi:10.1097/MD.0000000000021199.

    PMID: 32664167

This page provides educational information about BRBNS treatments, including Sirolimus and surgical options. It is not medical advice; always consult your specialist to determine the safest treatment plan for your specific symptoms.

Get notified when new evidence is published on Blue rubber bleb nevus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.